AI-powered R&D acceleration: Insilico Medicine and Hisun Pharma nominate a preclinical candidate just 8 months after forming a strategic collaboration
Business Announcement
Updates every hour. Last Updated: 27-May-2026 10:16 ET (27-May-2026 14:16 GMT/UTC)
From 1990 to 2021, global leukemia prevalence increased, whereas overall DALYs declined, indicating divergent trends between disease occurrence and health burden. Leukemia burden exhibited substantial heterogeneity across age, sex, subtype, and sociodemographic levels, with a pronounced bimodal age pattern and consistently higher burden in males. Chronic lymphocytic leukemia was the most prevalent subtype, while acute myeloid leukemia accounted for the largest share of DALYs; marked burden reductions were observed for ALL and CML. Burden decreased in high-SDI regions but continued to rise in low-SDI settings, highlighting persistent global inequalities in leukemia care. High body mass index, tobacco use, and occupational carcinogen exposure were key modifiable risk factors, and therapeutic advances likely contributed to DALY reductions, though benefits remain unevenly distributed.
This scoping review identifies the first wave of randomized controlled trials testing large language models in digestive diseases. Four published and ten ongoing trials suggest that AI tools such as ChatGPT are increasingly used for clinical decision-making and patient education, but robust, international evidence based on real patient outcomes is still urgently needed.
Cancer cachexia is commonly present in various cancers, including live, pancreatic, gastroesophageal, and bile duct cancers, and is associated with chemotherapy toxicity. M-MDSC induces mTEC apoptosis and impairs T cell negative selection, which leads to autoimmune T-cell infiltration of normal organs and serves as a prerequisite for the occurrence of irAEs. In addition, irAEs patients have higher levels of circulating M-MDSCs. M-MDSCs associated with cancer cachexia can serve as potential predictive biomarkers for irAE in advanced cancer patients.
Discover how human adipose tissue can be transformed into functional organoids representing all three germ layers—mesoderm, endoderm, and ectoderm—using a novel, streamlined method. This new study published in Engineering highlights the potential of adipose tissue for regenerative medicine, offering a scalable and clinically relevant alternative to traditional organoid generation techniques.
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential of AI to enhance RNA therapies, address current limitations, and unlock new opportunities for personalized medicine. Explore the future of AI-driven drug discovery and its impact on healthcare.
Researchers uncover a cunning new trick by which breast cancer cells evade immune attack. While the cGAS-STING pathway normally detects cytosolic DNA and activates anti-tumor immunity via IRF3-interferon signaling, aggressive tumors overexpress a long noncoding RNA, FAM83H-AS1, redirecting cGAS-STING signaling toward NF-κB-driven chronic inflammation that supports tumor growth. Critically, this shift creates a therapeutic vulnerability: NF-κB upregulates PD-L1, rendering these tumors highly susceptible to existing immunotherapies. This discovery reveals both a key mechanism for how cancer evades immunity and a promising way to fight back.